{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:12:45Z","timestamp":1784563965779,"version":"3.55.0"},"reference-count":12,"publisher":"Medknow","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Pharm Pract"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/2279-042x.108375","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T08:15:00Z","timestamp":1362730500000},"page":"77","source":"Crossref","is-referenced-by-count":27,"title":["The effect of pseudocatalase\/superoxide dismutase in the treatment of vitiligo: A pilot study"],"prefix":"10.4103","volume":"1","author":[{"given":"Bahareh","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Molaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FarahnazFatemi","family":"Naini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlirezaVaez","family":"Shooshtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2279-042X.108375-1","first-page":"160","volume-title":"Clinical practice.Vitiligo","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2279-042X.108375-2","first-page":"1","volume-title":"Neuro-immuno-endocrine processes in vitiligo pathogenesis","author":"Miniati","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key-10.4103\/2279-042X.108375-3","first-page":"381","volume-title":"Advanced treatment modalities for vitiligo","author":"Patel","year":"2012","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/2279-042X.108375-4","first-page":"1885","volume-title":"Vitiligo: An update on current pharmacotherapy and future directions","author":"Colucci","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/2279-042X.108375-5","first-page":"636","volume-title":"A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients","author":"Hazneci","year":"2005","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2279-042X.108375-6","first-page":"12","volume-title":"Oxidative stress in the blood of patients with active localized vitiligo","author":"Arican","year":"2008","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"key-10.4103\/2279-042X.108375-7","first-page":"721","volume-title":"Pseudocatalase and narrowband ultraviolet B for vitiligo: Clearing the picture","author":"Gawkrodger","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2279-042X.108375-8","first-page":"341","volume-title":"Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients","author":"Yuksel","year":"2009","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2279-042X.108375-9","first-page":"910","volume-title":"A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2279-042X.108375-10","doi-asserted-by":"crossref","unstructured":"Sanclemente G, Garcia JJ, Zuleta JJ, Diehl C, Correa C, Falabella R. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo. J Eur Acad Dermatol Venereol 2008;22:1359-64.","DOI":"10.1111\/j.1468-3083.2008.02839.x"},{"key":"key-10.4103\/2279-042X.108375-11","first-page":"969","volume-title":"Vitix- A new treatment for vitiligo?","author":"Schallreuter","year":"2005","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2279-042X.108375-12","first-page":"21","volume-title":"Ginkgo biloba for the treatment of vitilgo vulgaris: An open label pilot clinical trial","author":"Szczurko","year":"2011","journal-title":"BMC Complement Altern Med"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T05:02:42Z","timestamp":1498021362000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrpp.net\/text.asp?2012\/1\/2\/77\/108375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["108375"],"URL":"https:\/\/doi.org\/10.4103\/2279-042x.108375","relation":{},"ISSN":["2279-042X"],"issn-type":[{"value":"2279-042X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}